💡 Introducing Shailesh Joshi, MD, Senior Director of ICSR at PrimeVigilance.
Connect with Shailesh to explore how PrimeVigilance can elevate your pharmacovigilance efforts: https://t.co/C29qTfyNeL
#HealthcareLeadership#Innovation#Pharmacovigilance#PrimeVigilance
Welcome Julie! PrimeVigilance is pleased to announce that Julie Waldron has joined as Vice President of Business and Process Optimization.
Please join us in welcoming Julie to the Team!
#PrimeVigilance#Team#Leadership#NewHire#Pharmacovigilance
Today is Rare Disease Day, and we stand united in supporting awareness! 🧬
At PrimeVigilance, rare diseases are personal to us, fueling our unwavering dedication to improving the lives of those impacted by them. Let's stand united today!
#RareDiseaseAwareness#RareDiseaseDay
Ergomed Group is thrilled to announce the expansion of our global presence with a new office in Pune, India. As we continue to grow, our dedication to excellence remains steadfast, ensuring unparalleled support for our clients in the Asia-Pacific region.
https://t.co/v2IdJb9E3V
PrimeVigilance Medical Information expert will be attending the upcoming DIA Medical Affairs and Scientific Communications Forum 2024 in Orlando, FL, from March 6-8! 📑
Setup a meeting here: https://t.co/934kYQfrgI
#DIAForum#MedicalAffairs#PrimeVigilance#Orlando
Meet PrimeVigilance CGT/ATMP Expert: Tom Major 🚀
Tap into hist expert insights by registering for upcoming webinar: https://t.co/sZRATEkXJK
#ATMP#CGT#ExpertInsight#PatientCentricity
OPEN FOR REGISTRATION - Curious about the evolving landscape of Advanced Therapy Medicinal Products (ATMPs) / Cell & Gene Therapies (CGTs)?
Register now: https://t.co/sZRATEkXJK
#ATMP#CGT#Pharmacovigilance#Webinar
PrimeVigilance, an Ergomed Group company, is delighted to announce the strategic acquisition of Panacea, a company based in the Isle of Man, British Isles, recognised for delivering high quality, tailored PV solutions.
Please read full Article: https://t.co/WxAsIeLA4A
💊 PrimeVigilance stands at the forefront of the burgeoning Cell and Gene Therapies (CGT) / Advanced Therapy Medicinal Products (ATMP) sector, providing specialized and comprehensive support to organizations navigating this complex field.